ICG-001, A Novel Small Molecule Regulator of TCF/β-Catenin Masakatsu Transcription

Author(s): M. Eguchi, C. Nguyen, S. C. Lee, M. Kahn.

Journal Name: Medicinal Chemistry

Volume 1 , Issue 5 , 2005

Become EABM
Become Reviewer


Inherited and somatic mutations in the APC gene, a human tumor-suppressor, occur in a large percentage of colon cancers, leading to elevated levels of nuclear β-Catenin, and to activation of TCF/ β-Catenin-responsive genes including cyclin D1 and c-myc. To identify small molecule antagonists of this pathway, we screened transformed colorectal cells with a secondary structure-templated chemical library, in search of compounds that attenuated a TCF/ β- Catenin-responsive reporter gene. From this library we selected ICG-001 (IC50 = 3 M) as a lead compound. Design and synthesis of the chemical library and some preliminary biological evaluation is described.

Keywords: peptidomimetics, anti-cancer, wnt pathway, catenin

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [467 - 472]
Pages: 6
DOI: 10.2174/1573406054864098
Price: $65

Article Metrics

PDF: 24